Pharmaceutical Technology

SEPTEMBER 8, 2022

Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contract manufacturing market. Growth of oral solid dosage contract manufacturing in the pharmaceutical industry.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

Drug Discovery World

DECEMBER 14, 2023

The university contains the Medical Research Council (MRC)-University of Glasgow Centre for Virus Research (CVR), as well as CRUSH, part of CVR and established in partnership with LifeArc to address pandemic preparedness. For a growing company like BioAscent, there are huge advantages in being situated within a cluster.

Drugs 75

Drugs Life Science Research Scientist 75

Pharmaceutical Technology

JULY 4, 2022

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Several global pharma companies have already withdrawn their support following Russia’s invasion of Ukraine, which began on 24 February.

Pharma Production 305

Pharma Production Production Clinical Trials Clinical Trials 305

Pharmaceutical Technology

APRIL 24, 2023

“Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Pharmaceutical Technology

DECEMBER 6, 2022

On the other hand, the current trend is for fully closed systems that use negative pressure to keep particles contained inside isolators. Many companies are now prioritising investments in containment systems, GlobalData research shows. But containment is not only important at commercial-stage manufacturing.

Containment 130

Containment Development Drugs Contract Manufacturing 130

Pharmaceutical Technology

JUNE 14, 2023

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Of those, only 935 (34%) small molecule API facilities offered some type of containment capabilities.

Containment 130

Containment Manufacturing Contract Manufacturing Bioavailability 130